These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

916 related items for PubMed ID: 18266634

  • 1. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
    Verma A, Saraswat VA, Radha Krishna Y, Nath K, Thomas MA, Gupta RK.
    Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
    [Abstract] [Full Text] [Related]

  • 2. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
    Saksena S, Rai V, Saraswat VA, Rathore RS, Purwar A, Kumar M, Thomas MA, Gupta RK.
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
    [Abstract] [Full Text] [Related]

  • 3. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z, Zhao C, Yu L, Zhou W, Li K.
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [Abstract] [Full Text] [Related]

  • 4. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
    Tarasów E, Panasiuk A, Siergiejczyk L, Orzechowska-Bobkiewicz A, Lewszuk A, Walecki J, Prokopowicz D.
    Hepatogastroenterology; 2003 Apr; 50(54):2149-53. PubMed ID: 14696484
    [Abstract] [Full Text] [Related]

  • 5. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG, Nägele T, Seeger U, Hösl F, Gregor M, Kaiser S.
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [Abstract] [Full Text] [Related]

  • 6. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE, Urbanik A, Szczudlik A.
    Psychiatry Res; 2006 Dec 01; 148(2-3):111-20. PubMed ID: 17088051
    [Abstract] [Full Text] [Related]

  • 7. Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
    Geissler A, Lock G, Fründ R, Held P, Hollerbach S, Andus T, Schölmerich J, Feuerbach S, Holstege A.
    Hepatology; 1997 Jan 01; 25(1):48-54. PubMed ID: 8985263
    [Abstract] [Full Text] [Related]

  • 8. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study.
    Kulak W, Sobaniec W, Smigielska-Kuzia J, Kubas B, Walecki J.
    Dev Med Child Neurol; 2006 Apr 01; 48(4):285-9. PubMed ID: 16542516
    [Abstract] [Full Text] [Related]

  • 9. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
    Yildiz-Yesiloglu A, Ankerst DP.
    Psychiatry Res; 2006 Jun 30; 147(1):1-25. PubMed ID: 16806850
    [Abstract] [Full Text] [Related]

  • 10. Proton magnetic resonance spectroscopy (1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve.
    Lee JH, Seo DW, Lee YS, Kim ST, Mun CW, Lim TH, Min YI, Suh DJ.
    Am J Gastroenterol; 1999 Aug 30; 94(8):2206-13. PubMed ID: 10445551
    [Abstract] [Full Text] [Related]

  • 11. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
    Garcia M, Huppertz HJ, Ziyeh S, Buechert M, Schumacher M, Mader I.
    Epilepsia; 2009 Mar 30; 50(3):486-92. PubMed ID: 19183221
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus.
    Sahin I, Alkan A, Keskin L, Cikim A, Karakas HM, Firat AK, Sigirci A.
    J Diabetes Complications; 2008 Mar 30; 22(4):254-60. PubMed ID: 18413166
    [Abstract] [Full Text] [Related]

  • 13. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
    Iranzo A, Santamaria J, Pujol J, Moreno A, Deus J, Tolosa E.
    Sleep; 2002 Dec 30; 25(8):867-70. PubMed ID: 12489892
    [Abstract] [Full Text] [Related]

  • 14. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy.
    Chang Y, Woo ST, Lee JJ, Song HJ, Lee HJ, Yoo DS, Kim SH, Lee H, Kwon YJ, Ahn HJ, Ahn JH, Park SJ, Weon YC, Chung IS, Jeong KS, Kim Y.
    Neurotoxicology; 2009 Nov 30; 30(6):950-7. PubMed ID: 19631686
    [Abstract] [Full Text] [Related]

  • 15. MR spectroscopy in monitoring the treatment of Wilson's disease patients.
    Tarnacka B, Szeszkowski W, Golebiowski M, Czlonkowska A.
    Mov Disord; 2008 Aug 15; 23(11):1560-6. PubMed ID: 18546325
    [Abstract] [Full Text] [Related]

  • 16. Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.
    Kaymak SU, Demir B, Oğuz KK, Sentürk S, Uluğ B.
    Psychiatry Clin Neurosci; 2009 Jun 15; 63(3):350-6. PubMed ID: 19566767
    [Abstract] [Full Text] [Related]

  • 17. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
    Yücel M, Wood SJ, Wellard RM, Harrison BJ, Fornito A, Pujol J, Velakoulis D, Pantelis C.
    Aust N Z J Psychiatry; 2008 Jun 15; 42(6):467-77. PubMed ID: 18465373
    [Abstract] [Full Text] [Related]

  • 18. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct 15; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 19. Two-dimensional 1H MR spectroscopy of the brain in human immunodeficiency virus (HIV)-infected children.
    Banakar S, Thomas MA, Deveikis A, Watzl JQ, Hayes J, Keller MA.
    J Magn Reson Imaging; 2008 Apr 15; 27(4):710-7. PubMed ID: 18383256
    [Abstract] [Full Text] [Related]

  • 20. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD, Lyoo IK, Satlin A, Ahn KH, Kim MJ, Yurgelun-Todd DA, Cohen BM, Renshaw PF.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec 15; 28(8):1313-22. PubMed ID: 15588758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.